| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |